Shares Investor Evening (London)

Presenting

  • Allergy Therapeutics

    Allergy Therapeutics

    We provide information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy). Allergy vaccination is a successful treatment that deals with the underlying cause of allergies and not just the symptoms! Allergy Therapeutics has a long-term commitment to the development of innovative therapies for allergy treatment and allergy prevention.

  • Belvoir Group

    Belvoir Group

    Founded in 1995 and listed on AIM in 2012,Belvoir Group is the UKs largest property franchise operating nationwide from 396 offices across five brands specialising in residential lettings, property management, residential sales and property-related financial services. The Group manages 69,000 properties and reported record revenues of £19.3m in 2019.

  • CentralNic Group

    CentralNic Group

    CentralNic Group (CNIC) is a leading UK-headquartered global internet solutions company that operates in two highly attractive markets: high-growth digital advertising (Online Marketing segment) and domain name management solutions (Online Presence segment). The companys Online Marketing segment creates privacy-safe and AI-generated online consumer journeys that convert general interest online media users into confident high conviction consumers through advertorial and review websites. CentralNic is now over 200 times the size it was when it IPO-ed less than a decade ago. It has grown its profits every year and has been called "a cash generation machine."

  • Open Orphan

    Open Orphan

    Open Orphan (ORPH) is a rapidly growing niche CRO pharmaceutical services company which is the world leader in testing vaccines and antivirals through the use of human challenge clinical trials. Open Orphan is actively involved in the fight against COVID-19.